SIBN_logo.jpg
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
August 22, 2024 16:30 ET | SI-BONE, Inc.
SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be...
SIBN_logo.jpg
SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
August 20, 2024 08:30 ET | SI-BONE, Inc.
SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic...
SIBN_logo.jpg
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
August 06, 2024 08:30 ET | SI-BONE, Inc.
SANTA CLARA, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will be participating in...
SIBN_logo.jpg
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024
August 05, 2024 16:09 ET | SI-BONE, Inc.
Increases 2024 revenue guidance to $165 million - $167 millionExpects to achieve positive Adjusted EBITDA in Fourth Quarter 2024 SANTA CLARA, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc....
SIBN_logo.jpg
SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024
July 15, 2024 16:09 ET | SI-BONE, Inc.
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SIBN_logo.jpg
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
June 05, 2024 16:09 ET | SI-BONE, Inc.
SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SIBN_logo.jpg
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
May 07, 2024 09:00 ET | SI-BONE, Inc.
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic...
SIBN_logo.jpg
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
May 06, 2024 16:09 ET | SI-BONE, Inc.
SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SIBN_logo.jpg
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
April 29, 2024 09:00 ET | SI-BONE, Inc.
SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SIBN_logo.jpg
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
April 15, 2024 16:09 ET | SI-BONE, Inc.
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today...